Bio Japan 2009: The Biggest Biotechnology Event in Japan.

YOKOHAMA, Japan-(Business Wire)-September 29, 2009 - We would like to thank you sincerely for your understanding and ongoing cooperation for BioJapn.

With your wholehearted support, BioJapan has been progressing successfully in both its contents and scale every year.

This year, we are aiming to further expand the number of buy-side corporations such as pharmaceutical companies that are seeking seeds of a new technology by installing various alliance booths. We organize the alliance booths according to the areas such as drug-discovery, environment, and food so that we can facilitate optimal business matching for buy-sides and sell-sides including ventures, research institutions such as universities and TLOs, and other regional organizations.

The following companies are planning to participate in this event at this moment.

Takeda Pharmaceutical, Astellas Pharma, Daiichi Sankyo, Eisai, Mitsubishi Tanabe Pharma, Chugai Pharmaceutical, Kyowa Hakko Kirin, Shionogi, Dainippon Sumitomo Pharma, Merck Banyu Pharmaceutical, Roche Pharma Japan, Novartis Pharma, Sanofi Aventis, Janssen Pharma, Sandoz, Genzyme, Johnson & Johnson, Dupont, TORE, Asahi Glass, Terumo, Medtronic Japan, GE Healthcare Bio-Sciences, Ushio, Takara Bio, Kaneka, Ajinomoto, JT, Sapporo Beer, Suntory, Kao, Meiji Seika (total 31 companies)

We will expand our participant list by inviting more corporations in various fields including medical device and bio fuel businesses. Since BioJapan draws one of the largest numbers of buy-side corporations among Japan's bio-related exhibitions, this event can be the best business opportunities for many. We hope you would decide to participate in our event.

Further information of this event is available from the following website: